Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Biologics · 2007 · PMC2721295 · PMID 19707312

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

If this 24 hour difference in onset of action is a general phenomenon that distinguishes the two, it could be highly significant for therapeutic applications.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.